What is Nektar Therapeutics's cash ratio?

Nektar Therapeutics (NKTR) reported cash ratio of 0.1× in Q1 2026.

How has Nektar Therapeutics's cash ratio changed year-over-year?

Nektar Therapeutics's cash ratio decreased by 1.6% year-over-year, from 0.1× to 0.1×.

What is the long-term trend for Nektar Therapeutics's cash ratio?

Over 5 years (2020 to 2025), Nektar Therapeutics's cash ratio has grown at a 1.9% compound annual growth rate (CAGR), from 0.1× to 0.1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Nektar Therapeutics NKTR Cash ratio

Cash ratio at other companies

AmgenAMGN

0×0.0×

Regeneron PharmaceuticalsREGN

0.6×-0.3×

ImmunityBio, Inc.IBRX

3×+1.8×

Apogee Therapeutics, Inc.APGE

13.7×+10.5×

ImmunomeIMNM

21.3×+12.9×

Vera TherapeuticsVERA

2.5×0.0×

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

cash and equivalents/total current liabilities=0.1×

Based on the most recent quarter.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's cash ratio?: Nektar Therapeutics (NKTR) reported cash ratio of 0.1× in Q1 2026.
How has Nektar Therapeutics's cash ratio changed year-over-year?: Nektar Therapeutics's cash ratio decreased by 1.6% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Nektar Therapeutics's cash ratio?: Over 5 years (2020 to 2025), Nektar Therapeutics's cash ratio has grown at a 1.9% compound annual growth rate (CAGR), from 0.1× to 0.1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.